liver 英 [ˈlɪvə(r)] 美 [ˈlɪvɚ]
释义 n. 肝脏；生活者，居民
例句 They also found particles in the liver cells of patients with hepatitis.
biopsy 英 [ˈbaɪɒpsi] 美 [ˈbaɪɑ:psi]
释义 n. 活组织检查；活组织切片检查；切片检查法
例句 Open lung biopsy demonstrated GVHD.
作者： Megan J. Sue
期刊：Clinical and Translational Gastroenterology
Transjugular liver biopsy (TJLB) is a safe and efficacious method of obtaining hepatic tissue samples for histopathologic analysis (1–3). First developed in 1964 as an alternative to percutaneous liver biopsy, TJLB can be safely performed in high-risk patients or those requiring simultaneous hepatic hemodynamic measurements(1,2,4–6). By using a vascular access route rather than a percutaneous one, TJLB greatly reduces the risk of hemorrhage secondary to compromise of the hepatic arterial or portal venous system (7,8). However, TJLB is not without risk. Minor complications including abdominal pain, capsular perforation, neck hematoma, fever, and hypotension have been associated with the procedure (9–11). In addition, extremely rare major complications such as intraperitoneal hemorrhage, retroperitoneal hemorrhage, and death have also been reported (4,8,10,11). However, because any potential post-biopsy bleeding may occur intravascularly, the risk of some of the major complications is minimized (1,6). As such, a transjugular approach is the preferred biopsy method in high-risk patients: those with coagulopathy, coagulation disorders, or high-volume ascites and those not clinically stable enough to tolerate percutaneous procedures (1,4). Diagnostic efficacy and the quality of specimens obtained by TJLB are comparable to those obtained by a percutaneous route, with success rates approaching 87%–98% (4,10,11).